Shopping Cart (0)
My Account

Your Shopping Cart
Circulating Tumor Cells

Circulating Tumor Cells



Our 2nd annual Circulating Tumour Cells 2012 conference is expanding on the interest expressed in the CTC sessions of our very popular Single Cell Analysis conferences.

With oncologists increasingly using CTCs to gather prognostic information on their patients, it is more and more apparent that CTCs can offer clinicians a non-invasive means of sampling for genetic markers, monitoring treatment responsiveness, aiding in treatment decision-making and indicating novel drug targets.
However, there are still issues and questions being raised about the clinical significance of CTCs, as well as the need to improve sensitivity, reproducibility and reliability of their use in disease monitoring. To solve these problems there is a real need for increased collaboration and understanding if the industry is to effectively use CTCs to improve cancer survival rates and provide significant cost-savings.

The Circulating Tumor Cells 2012 conference and exhibition offers delegates 2 days of world class speakers who are at the forefront of the field and whose talks will be exploring, as well as attempting to answer, some of these CTC questions.

Other conference tracks at this event include Cell Based Assays, Cell Culture, Cancer Stem Cells and Flow Cytometry.

Running alongside the conference will be an exhibition covering the latest technological advances and associated services within these fields.


Keynote Speakers

Dario Marchetti

Dario Marchetti
Professor/Director, Baylor College of Medicine

Katharina Pachmann

Katharina Pachmann
Professor, University of Jena

Agenda Topics

  • CTCs as Prognostic or Predictive Biomarkers for Cancer
  • Early Cancer Detection
  • EMT in Cell Generation and Survival
  • Isolation and Analysis of CTCs: Emerging Technologies Impacting the Field
  • Methods of Enumeration of CTCs as a Predictor
  • Novel Methods for Detection and Profiling
  • Significance of CTCs in Various Types of Cancer: Liquid Tumors vs. Solid Tumors
  • The Formation and Markers for Circulating Tumor Cells
  • The use of Circulating Tumour Cells in Clinical Development
  • Understanding the Role of EMT in Metastasis

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44(0)1787 315110

Confirmed Speakers to date

Enal Razvi, Managing Director, Select Biosciences, Inc.
Samir Hanash, Program Head, Fred Hutchinson Cancer Research Center
Hsian-Rong Tseng, Associate Professor, University of California Los Angeles
Dave Hoon, Director, Molecular Oncology and Chief of Scientific Intelligence, John Wayne Cancer Institute
Jean-Louis Viovy, Group Leader, Université Pierre et Marie Curie
Henry Lin, Graduate Student, University of California
Lidia Sambucetti, Senior Director, SRI International
Andrew Rhim, Instructor of Medicine, University of Pennsylvania School of Medicine
Iman Jilani, Associate Director, Pfizer
Jeff Chalmers, Director, The Ohio State University
Anand Kolatkar, Researcher, Scripps Research Institute
Pamela Paris, Associate Professor, University of California San Francisco


Corporate Sponsors Media Sponsors Networking
U-Networks




There is currently no news for this track.
    Keep me updated Select Bio Blog Linked in Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com